393 related articles for article (PubMed ID: 15780329)
1. The trend of pulmonary tuberculosis in patients seen at DOTS clinics in the Federal Capital Territory, Abuja, Nigeria.
Bassey EB; Momoh MA; Imadiyi SO; Udofia EB; Miri FS; Anukam KC; Epoke J; Benka-Coker MO; Aluyi HS
Public Health; 2005 May; 119(5):405-8. PubMed ID: 15780329
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology and endemicity of pulmonary tuberculosis (PTB) in Southeastern Nigeria.
Itah AY; Udofia SM
Southeast Asian J Trop Med Public Health; 2005 Mar; 36(2):317-23. PubMed ID: 15916036
[TBL] [Abstract][Full Text] [Related]
3. Relationship between sputum smear grading and smear conversion rate and treatment outcome in the patients of pulmonary tuberculosis undergoing dots--a prospective cohort study.
Tiwari S; Kumar A; Kapoor SK
Indian J Tuberc; 2012 Jul; 59(3):135-40. PubMed ID: 23362709
[TBL] [Abstract][Full Text] [Related]
4. Ten years experience of directly observed treatment short-course (dots) therapy for tuberculosis in Addis Ababa, Ethiopia.
Woldeyohannes D; Kebede N; Erku W; Tadesse Z
Ethiop Med J; 2011 Jul; 49(3):221-9. PubMed ID: 21991755
[TBL] [Abstract][Full Text] [Related]
5. Tuberculosis control in Bangladesh: success of the DOTS strategy.
Kumaresan JA; Ahsan Ali AK; Parkkali LM
Int J Tuberc Lung Dis; 1998 Dec; 2(12):992-8. PubMed ID: 9869115
[TBL] [Abstract][Full Text] [Related]
6. TB situation in Albania, 2001-2008.
Hafizi H; Tafaj S; Bardhi D; Dilko E; Aliko A
Pneumologia; 2009; 58(2):104-7. PubMed ID: 19637762
[TBL] [Abstract][Full Text] [Related]
7. Treatment results of DOTS in 1797 Sudanese tuberculosis patients with or without HIV co-infection.
El-Sony AI; Khamis AH; Enarson DA; Baraka O; Mustafa SA; Bjune G
Int J Tuberc Lung Dis; 2002 Dec; 6(12):1058-66. PubMed ID: 12546113
[TBL] [Abstract][Full Text] [Related]
8. DOTS in Cambodia. Directly observed treatment with short-course chemotherapy.
Norval PY; San KK; Bakhim T; Rith DN; Ahn DI; Blanc L
Int J Tuberc Lung Dis; 1998 Jan; 2(1):44-51. PubMed ID: 9562110
[TBL] [Abstract][Full Text] [Related]
9. The DOTS strategy for treatment of paediatric pulmonary tuberculosis in South Delhi, India.
Sharma S; Sarin R; Khalid UK; Singla N; Sharma PP; Behera D
Int J Tuberc Lung Dis; 2008 Jan; 12(1):74-80. PubMed ID: 18173881
[TBL] [Abstract][Full Text] [Related]
10. Tuberculosis drug resistance and treatment outcomes under DOTS settings in large cities in the Philippines.
Ohkado A; Aguiman L; Adlawan S; Baring E; Quirante O; Suchi M; Endo S; Fujiki A; Mori T
Int J Tuberc Lung Dis; 2006 Mar; 10(3):283-9. PubMed ID: 16562708
[TBL] [Abstract][Full Text] [Related]
11. Pattern of active pulmonary tuberculosis in human immunodeficiency virus seropositive adult patients in University College Hospital, Ibadan, Nigeria.
Awoyemi OB; Ige OM; Onadeko BO
Afr J Med Med Sci; 2002 Mar; 31(1):25-31. PubMed ID: 12518925
[TBL] [Abstract][Full Text] [Related]
12. Five year review of treatment outcome of directly observed therapy (DOT) for re-treatment pulmonary tuberculosis patients in UCH, Ibadan, Nigeria.
Ige OM; Akindele MO
Afr J Med Med Sci; 2011 Mar; 40(1):15-21. PubMed ID: 21834257
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of DOTS strategy in treatment of respiratory tuberculosis in Gorgan, Islamic Republic of Iran.
Abassi A; Mansourian AR
East Mediterr Health J; 2007; 13(3):664-9. PubMed ID: 17687840
[TBL] [Abstract][Full Text] [Related]
14. Compliance in pulmonary tuberculosis patients using directly observed treatment short course.
Dosumu EA
Afr J Med Med Sci; 2001; 30(1-2):111-4. PubMed ID: 14510163
[TBL] [Abstract][Full Text] [Related]
15. Retrospective descriptive study of adult tuberculosis in Wuhan, China.
Chamla DD; Nie S; Duan Q
Int J Tuberc Lung Dis; 2004 Jun; 8(6):730-6. PubMed ID: 15182143
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of drug resistance under the DOTS strategy in Hyderabad, South India, 2001-2003.
Anuradha B; Aparna S; Hari Sai Priya V; Vijaya Lakshmi V; Akbar Y; Suman Latha G; Murthy KJ
Int J Tuberc Lung Dis; 2006 Jan; 10(1):58-62. PubMed ID: 16466038
[TBL] [Abstract][Full Text] [Related]
17. Tuberculosis recurrence and mortality after successful treatment: impact of drug resistance.
Cox H; Kebede Y; Allamuratova S; Ismailov G; Davletmuratova Z; Byrnes G; Stone C; Niemann S; Rüsch-Gerdes S; Blok L; Doshetov D
PLoS Med; 2006 Oct; 3(10):e384. PubMed ID: 17020405
[TBL] [Abstract][Full Text] [Related]
18. Profile of geriatric patients under DOTS in Revised National Tuberculosis Control Programme.
Arora VK; Singla N; Sarin R
Indian J Chest Dis Allied Sci; 2003; 45(4):231-5. PubMed ID: 12962456
[TBL] [Abstract][Full Text] [Related]
19. [Epidemiologic aspects of pulmonary tuberculosis with positive bacilloscopy in the decade of 1995-2004].
Diallo S; Dao S; Dembele JP; Toloba Y; Kassambara H; Berthe M; Bougoudogo F; Diallo
Mali Med; 2008; 23(2):25-9. PubMed ID: 19434964
[TBL] [Abstract][Full Text] [Related]
20. Community vs. facility-based directly observed treatment for tuberculosis in Tanzania's Kilimanjaro Region.
van den Boogaard J; Lyimo R; Irongo CF; Boeree MJ; Schaalma H; Aarnoutse RE; Kibiki GS
Int J Tuberc Lung Dis; 2009 Dec; 13(12):1524-9. PubMed ID: 19919771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
